Assessment of a life-time optimization of extracorporeal support systems by D-dimers as fibrinolytic parameter;Bewertung einer laufzeitoptimierung von extrakorporalen unterstützungssystemen durch D-dimere als fibrinolyseparameter

Kardiotechnik

Volumn 16, Issue 2, 2007, Pages 33-36

  Gehron, Johannes ^a   Thul, J ^a   Valeske, K ^a   Schranz, D ^a   Akinturk H ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Anticoagulation; Clot formation; Extracorporeal Life Support; Haemostasis; Markers of activation; Prognostic methods; Time series analysis

Indexed keywords

BIOLOGICAL MARKER; D DIMER; FIBRIN; HEPARIN;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL OXYGENATION; FIBRINOLYSIS; HEART FAILURE; HEMOSTASIS; HUMAN; PARAMETER; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDY; THROMBOEMBOLISM; TIME SERIES ANALYSIS;

EID: 34447566139     PISSN: 09412670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Arnold P, Jackson S, Wallis J, Smith J, Bolton D, Haynes S: Coagulation factor activity during neonatal extra-corporeal membrane oxygenation. Intensive Care Med 2001; 27(8): 1395-1400
2. Sevan DH: Cardiac bypass haemostasis: putting blood through the mill. Br J Haematol 1999; 104(2): 208-219
3. Boeken U, Litmathe J, Feindt P, Gams E: Neurological complications after cardiac surgery: risk factors and correlation to the surgical procedure. Thorac Cardiovasc Surg 2005; 53(1): 33-36
4. Hamrick SE, Gremmels DB, Keet CA, Leonard CH, Connell JK, Hawgood S et al: Neurodevelopmental outcome of infants supported with extracorporeal membrane oxygenation after cardiac surgery. Pediatrics 2003; 111 (6 Pt 1): e671-675
5. Heim SW, Schectman JM, Siadaty MS, Philbrick JT: D-dimer testing for deep venous thrombosis: a metaanalysis. Clin Chem 2004; 50(7): 1136-1147
6. Ibrahim AE, Duncan BW, Blume ED, Jonas RA: Long-term follow-up of pediatric cardiac patients requiring mechanical circulatory support. Ann Thorac Surg 2000; 69: 186-192
7. Lequier L, Chan A: Anticoagulation during extracorporeal life support. Prog Pediatr Cardiol 2005; 21(1): 81-85
8. Lowe GD: Virchow's triad revisited: abnormal flow. Pathophysiol Haemost Thromb 2003/2004; 33(5-6): 455-457
9. Muntean W: Coagulation and anticoagulation in extracorporeal membrane oxygenation. Artif Organs 1999; 23(11): 979-983
10. Paparella D, Brister SJ, Buchanan MR: Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 2004; 30(10): 1873-1881
11. Urlesberger B, Zobel G, Zenz W, Kuttnig-Haim M, Maurer U, Reiterer F et al: Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants. J Pediatr 1996; 129(2): 264-268
12. Urlesberger B, Zobel G, Rodl S, Dacar D, Friehs I, Leschnik B, Muntean W: Activation of the clotting system: heparin-coated versus non-coated systems for extracorporeal circulation. Int J Artif Organs 1997; 20(12): 708-712
13. Webb AR, Mythen MG, Jacobson D, Mackie IJ: Maintaining blood flow in the extracorporeal circuit: haemostasis and anticoagulation. Intensive Care Med 1995; 21(1): 84-93
14. Zeger SL, Irizarry R, Peng RD: On time series analysis of public health and biomedical data. Annu Rev Public Health 2006; 27